Individual Patient Expanded Access-Glembatumumab Vedotin
NCT03067935
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Metastatic gpNMB Expressing Triple Negative Breast Cancer
Interventions
DRUG:
glembatumumab vedotin
Sponsor
Celldex Therapeutics